Clinical trial
Bundled Hyperpolypharmacy Deprescribing: Implementation and Evaluation of a System-wide Quality Improvement Intervention
NCT05616689 is registered in ClinicalTrials.gov with Kaiser Permanente as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Bundled Hyperpolypharmacy Deprescribing: Implementation and Evaluation of a System-wide Quality Improvement Intervention
- Lead sponsor
- Kaiser Permanente
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 19, 2020
- Completion date
- May 24, 2023
- Enrollment
- 2,471 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
polypharmacy